Mary Jenkins Annalisa's most recent trade in Skye Bioscience Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skye Bioscience Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Mereo Biopharma Grp PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 106,848 | 106,848 | - | - | Deferred Restricted Stock Units | |
| Mereo Biopharma Grp PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 66,000 | 66,000 | - | - | Share Options (Right to buy) | |
| Skye Bioscience Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Compass Pathways PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 26,000 | 26,000 | - | - | Share Option (Right to Buy) | |
| Skye Bioscience Inc | Annalisa Jenkins Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Mereo Biopharma Grp PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 15,243 | 15,243 | - | - | Deferred Restricted Stock Units | |
| Skye Bioscience Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Compass Pathways PLC (ADR) | Annalisa Mary Jenkins | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.88 per share. | 01 Aug 2024 | 161 | 19,480 | - | 6.9 | 1,108 | Ordinary Shares |
| Compass Pathways PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 26,000 | 26,000 | - | - | Share Option (Right to Buy) | |
| Compass Pathways PLC (ADR) | Annalisa Mary Jenkins | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.48 per share. | 01 May 2024 | 211 | 19,641 | - | 8.5 | 1,789 | Ordinary Shares |
| Mereo Biopharma Grp PLC (ADR) | Mary Jenkins Annalisa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Grp PLC (ADR) | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 14,947 | 14,947 | - | - | Deferred Restricted Stock Units | |
| Compass Pathways PLC (ADR) | Jenkins Annalisa Mary | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.34 per share. | 01 Feb 2024 | 175 | 19,852 | - | 11.3 | 1,985 | Ordinary Shares |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 17,643 | 17,643 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 17,478 | 17,478 | - | - | Stock Option (Right to Buy) | |
| Tectonic Therapeutic Inc | Annalisa Mary Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 17,438 | 17,438 | - | - | Stock Option (Right to Buy) |